Baseline Kinetics of Clot Waveform Analysis of Clotting Screening Tests on Sysmex CS2500 Automated Coagulometry

Author:

Kumar Bhola Rajesh1ORCID,Biswal Tapan1ORCID,Pradhan Sarita1ORCID,Mohanty Ripunjaya1ORCID,Behera Gayatri1ORCID

Affiliation:

1. Laboratory Hematology Division, Department of Pathology, IMS and SUM Hospital, Siksha ‘O’ Anusandhan (Deemed to be) University, Bhubaneswar, Odisha, India

Abstract

Clot waveforms generated by different automated coagulometry are of immense utility in predicting the risk of bleeding or thrombosis. They are part of global hemostasis testing. Different automated analyzers use different technology for clotting screening tests. The clotting screening results depends on the instrument and the reagents used. Hence clot waveform analysis may have different kinetics based on instrument or reagents used. A baseline characteristic can help in clinical interpretation.Total 47 voluntary blood donors (23 males and 24 females) between 20-50 years age are included in the study. We have analyzed the kinetics of clot waveform of Prothrombin time (PT) using Dade Innovin, activated partial thromboplastin time (aPTT) using Actin FS & Actin FSL and thrombin time (TT) on Sysmex CS2500 automated coagulometry. The baseline characteristics were analyzed and the reference intervals were determined as follows: PT using Dade Innovin reagent: 9.8 – 12.0s, its 1st derivative or maximum velocity (min1): 1.00-2.42 %/s, 2nd derivative or maximum acceleration (min2): 0.14-0.38%/s2, maximum deceleration (max2): 0.18-0.42 %/s2; aPTT using actin FSL: 26.2-34.5s, min1 2.73-6.17%/s, min2 0.41-0.95%/s2, max2 0.30-0.77 %/s2 ; aPTT using actin FS reagent: 21.2-30.5s, min1 2.73-6.33 %/s, min2 0.37-1.07 %/s2, max2 0.32-0.94 %/s2 ; TT: 16.8-19.6 s, min1 0.57-1.23 %/s, min2 0.08-0.20 %/s2, max2 0.03-0.11 %/s2 respectively. The clotting time shows an inverse moderate to weak relationship with maximum velocity, maximum acceleration and maximum deceleration. Analyzing the normal kinetics of clot waveform helps in understanding the clotting process and clinical interpretation.

Publisher

Oriental Scientific Publishing Company

Subject

Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3